Russell Cox is the founder of Epirium Bio. Epirium Bio has raised $85M in total funding. Latest round: Series A. Based in San Francisco, United States.
Russell Cox is the President and CEO of Epirium Bio, a clinical-stage biopharmaceutical company. The company focuses on developing therapeutics that optimize tissue bioenergetics and structure through a novel mechanism of action, initially targeting rare neuromuscular diseases like Becker Muscular Dystrophy. In December 2019, Epirium Bio raised $85 million in Series A financing.
Full founder directory · Investor directory · Company funding database · Fundraising library